Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Baker Bros Advisors LP | 9.40M (498.84%) | 0.00 Increased by 0.00% | Sep 30, 24 |
2 | Deep Track Capital, LP | 3.55M (188.29%) | 57.49K Increased by +1.62% | Sep 30, 24 |
3 | Paradigm Biocapital Advisors LP | 3.25M (172.30%) | -460.24K Decreased by -14.18% | Mar 31, 24 |
4 | FCPM III SERVICES BV | 2.34M (124.18%) | 217.07K Increased by +9.28% | Sep 30, 24 |
5 | RA Capital Management, LLC | 2.25M (119.56%) | 0.00 Increased by 0.00% | Sep 30, 24 |
6 | Armistice Capital, LLC | 1.96M (103.80%) | -16.00K Decreased by -0.82% | Sep 30, 24 |
7 | Jefferies Financial Group Inc | 1.95M (103.38%) | 0.00 Increased by 0.00% | Dec 31, 23 |
8 | Westfield Capital Management Company, L.P. | 1.85M (98.23%) | 327.09K Increased by +17.67% | Sep 30, 24 |
9 | Westfield Capital Management Company, LP | 1.85M (98.23%) | 327.09K Increased by +17.67% | Sep 30, 24 |
10 | T. Rowe Price Associates, Inc. | 1.72M (91.39%) | 923.54K Increased by +53.63% | Sep 30, 24 |
11 | Tybourne Capital Management (HK) Ltd | 1.39M (74.01%) | -115.18K Decreased by -8.26% | Sep 30, 24 |
12 | Morgan Stanley - Brokerage Accounts | 1.35M (71.64%) | -1.11M Decreased by -82.47% | Sep 30, 24 |
13 | BRAIDWELL LP | 1.29M (68.45%) | 1.29M Increased by +100.00% | Sep 30, 23 |
14 | Fairmount Funds Management LLC | 1.07M (56.74%) | 1.07M Increased by +100.00% | Jun 30, 24 |
15 | Candriam Luxembourg S.C.A. | 1.05M (55.75%) | 291.42K Increased by +27.74% | Sep 30, 24 |
16 | Polar Capital Holdings PLC | 1.00M (53.22%) | -1.75K Decreased by -0.18% | Sep 30, 24 |
17 | First Light Asset Management, LLC | 967.01K (51.32%) | -417.76K Decreased by -43.20% | Sep 30, 24 |
18 | Camber Capital Management LLC | 915.00K (48.56%) | 0.00 Increased by 0.00% | Sep 30, 24 |
19 | Suvretta Capital Management, LLC | 914.48K (48.53%) | 0.00 Increased by 0.00% | Mar 31, 24 |
20 | HHG PLC | 910.93K (48.34%) | -370.39K Decreased by -40.66% | Sep 30, 23 |
Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | T. Rowe Price Health Sciences | 1.33M (70.63%) | -1.41K Decreased by -0.11% | Oct 31, 24 |
2 | Polar Capital Biotech S Inc | 890.62K (47.26%) | -109.38K Decreased by -12.28% | Oct 31, 24 |
3 | Harbor Small Cap Growth Instl | 847.47K (44.97%) | 151.69K Increased by +17.90% | Sep 30, 24 |
4 | Westfield Capital Mgt Co Sm-Cap Gr Eq | 695.78K (36.92%) | 234.44K Increased by +33.69% | Jun 30, 24 |
5 | BNP Paribas Health Cr Innovtr Cl Cap | 558.59K (29.64%) | 33.78K Increased by +6.05% | Oct 31, 24 |
6 | Candriam Eqs L Biotech C USD Cap | 558.46K (29.64%) | 0.00 Increased by 0.00% | Oct 31, 24 |
7 | Belfius Equities Cure C Cap | 498.23K (26.44%) | 6.11K Increased by +1.23% | Nov 30, 24 |
8 | Candriam Global Equities Oncology | 492.11K (26.12%) | 125.18K Increased by +25.44% | Sep 30, 24 |
9 | Janus Henderson Global Life Sciences | 385.75K (20.47%) | -89.69K Decreased by -23.25% | Sep 30, 23 |
10 | Janus Henderson Global Life Sciences D | 385.75K (20.47%) | -89.69K Decreased by -23.25% | Sep 30, 23 |
11 | Janus Selection Global Life Science AUSD | 298.27K (15.83%) | -76.67K Decreased by -25.71% | Sep 30, 23 |
12 | BNP Paribas US Small Cap Classic R | 285.01K (15.12%) | 49.69K Increased by +17.44% | Oct 31, 24 |
13 | AXA Framlington Health R Inc | 279.70K (14.84%) | -8.49K Decreased by -3.03% | Nov 30, 23 |
14 | AXA Framlington Health Fund - R Income | 273.98K (14.54%) | 0.00 Increased by 0.00% | Oct 31, 24 |
15 | UTM IM GBP AXA Framlington Biotech | 268.72K (14.26%) | 0.00 Increased by 0.00% | Oct 31, 24 |
16 | Fidelity Select Biotechnology | 266.35K (14.13%) | 0.00 Increased by 0.00% | Dec 31, 23 |
17 | Fidelity® Select Biotechnology | 266.35K (14.13%) | 0.00 Increased by 0.00% | Nov 30, 23 |
18 | iShares Biotechnology ETF | 264.89K (14.06%) | 0.00 Increased by 0.00% | Nov 30, 24 |
19 | Principal U.S. Small Cap Equity | 201.90K (10.71%) | 201.90K Increased by +100.00% | Sep 30, 24 |
20 | Handelsbanken Hälsovård Tema (A1 SEK) | 200.00K (10.61%) | 0.00 Increased by 0.00% | Nov 30, 24 |